Literature DB >> 8283080

Secretin-cerulein test and fecal chymotrypsin concentration in children with intestinal giardiasis.

A Carroccio1, G Iacono, G Montalto, F Cavataio, D Lorello, A Notarbartolo.   

Abstract

We studied six patients with giardiasis (five males, one female), median age 3.5 yr (range 1-11) and 12 healthy control subjects (10 males, 2 females), median age 3.5 yr (range 1-10). Intestinal biopsy and a contemporaneous secretin-cerulein test were performed in all patients, and fecal chymotrypsin was also assayed. Intestinal biopsy was normal in five of the six patients with giardiasis, whereas one of the six presented a partial atrophy of the intestinal villi. The secretin-cerulein test (1 CU/kg of secretin + 75 ng/kg of cerulein) did not show any significant difference between values in the outputs of chymotrypsin, lipase, phospholipase, and bicarbonate obtained in patients and in controls; however, in the one patient with partial intestinal mucosal atrophy, all enzymatic activity levels were below the normal limit for our laboratory. Furthermore, the mean values of fecal chymotrypsin concentration did not differ between the two groups. Fecal chymotrypsin was also reduced in the patient with an abnormal secretin-cerulein test; a second assay performed 3 mo after the suspension of treatment (Metronidazole), however, showed a normal chymotrypsin concentration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8283080     DOI: 10.1007/BF02786124

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  12 in total

1.  Tryptic activity in the duodenal aspirate following a standard test meal in giardiasis.

Authors:  L S Chawla; A K Sehgal; S L Broor; R S Verma; P N Chhuttani
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

2.  Investigation of exocrine pancreatic function by continuous infusion of caerulein and secretin in normal subjects and in chronic pancreatitis.

Authors:  L Gullo; P L Costa; G Fontana; G Labò
Journal:  Digestion       Date:  1976       Impact factor: 3.216

3.  Relation of giardiasis to abnormal intestinal structure and function in gastrointestinal immunodeficiency syndromes.

Authors:  M E Ament; C E Rubin
Journal:  Gastroenterology       Date:  1972-02       Impact factor: 22.682

4.  Giardiasis in children: a study of pancreatic functions.

Authors:  R K Gupta; S Mehta
Journal:  Indian J Med Res       Date:  1973-05       Impact factor: 2.375

5.  Malabsorption in giardiasis.

Authors:  S N Khosla; S V Sharma; S C Srivastava
Journal:  Am J Gastroenterol       Date:  1978-06       Impact factor: 10.864

6.  Time-related enzyme concentrations in duodenal aspirates after ingestion of a test meal.

Authors:  I Ihse; P Lilja; A Evander; G Skude
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

7.  Exocrine pancreatic function of children from the Ivory Coast compared to French children. Effect of kwashiorkor.

Authors:  J F Sauniere; H Sarles; Y Attia; A Lombardo; T N Yoman; R Laugier; K Manlan; J Sahel
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

8.  Giardia-induced malabsorption in pancreatitis.

Authors:  T W Sheehy; H P Holley
Journal:  JAMA       Date:  1975-09-29       Impact factor: 56.272

9.  Exocrine pancreatic function in children with coeliac disease before and after a gluten free diet.

Authors:  A Carroccio; G Iacono; G Montalto; F Cavataio; C Di Marco; V Balsamo; A Notarbartolo
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

Review 10.  Giardia and giardiasis in childhood.

Authors:  J C Craft
Journal:  Pediatr Infect Dis       Date:  1982 May-Jun
View more
  1 in total

1.  Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology.

Authors:  A Carroccio; F Verghi; B Santini; V Lucidi; G Iacono; F Cavataio; M Soresi; N Ansaldi; M Castro; G Montalto
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.